Inhibition of UGT1A1 by natural and synthetic flavonoids.

[1]  Tanaka, , 2020, Catalysis from A to Z.

[2]  J. Chen,et al.  Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1. , 2018, International journal of biological macromolecules.

[3]  Guangbo Ge,et al.  Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism. , 2018, International journal of biological macromolecules.

[4]  Ye Qi,et al.  Inhibitory mechanism and molecular analysis of furoic acid and oxalic acid on lipase. , 2018, International journal of biological macromolecules.

[5]  Tongyi Dou,et al.  Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review , 2018, Biotechnology journal.

[6]  M. Finel,et al.  Recent progress and challenges in screening and characterization of UGT1A1 inhibitors , 2018, Acta pharmaceutica Sinica. B.

[7]  M. Anese,et al.  Effect of coffee roasting on in vitro α-glucosidase activity: Inhibition and mechanism of action. , 2018, Food research international.

[8]  Guangbo Ge,et al.  Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases. , 2018, Chemico-biological interactions.

[9]  Guangbo Ge,et al.  A Practical and High-Affinity Fluorescent Probe for Uridine Diphosphate Glucuronosyltransferase 1A1: A Good Surrogate for Bilirubin. , 2017, Journal of medicinal chemistry.

[10]  Tongyi Dou,et al.  Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Guangbo Ge,et al.  Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1 , 2017, Acta pharmaceutica Sinica. B.

[12]  Jianbo Xiao,et al.  Flavonoids as modulators of metabolic enzymes and drug transporters , 2017, Annals of the New York Academy of Sciences.

[13]  Ying Xie,et al.  Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD , 2017, Molecules.

[14]  B. Yan,et al.  Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a. , 2016, Experimental and therapeutic medicine.

[15]  Hongbing Wang,et al.  Insights into CYP2B6-mediated drug–drug interactions , 2016, Acta pharmaceutica Sinica. B.

[16]  Guangbo Ge,et al.  Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases. , 2016, Toxicology and applied pharmacology.

[17]  Guangbo Ge,et al.  Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  B. Goh,et al.  UGT1A1 Mediated Drug Interactions and its Clinical Relevance. , 2016, Current drug metabolism.

[19]  R. Tukey,et al.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. , 2015, Toxicology and applied pharmacology.

[20]  Guangbo Ge,et al.  Identification and characterization of naturally occurring inhibitors against UDP-glucuronosyltransferase 1A1 in Fructus Psoraleae (Bu-gu-zhi). , 2015, Toxicology and applied pharmacology.

[21]  Liang Xu,et al.  C-8 Mannich base derivatives of baicalein display improved glucuronidation stability: exploring the mechanism by experimentation and theoretical calculations , 2015 .

[22]  M. Finel,et al.  An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications. , 2015, Biosensors & bioelectronics.

[23]  Manjinder Singh,et al.  Flavones: an important scaffold for medicinal chemistry. , 2014, European journal of medicinal chemistry.

[24]  Michèle Rouleau,et al.  Pharmacogenomics of Human Uridine Diphospho‐Glucuronosyltransferases and Clinical Implications , 2014, Clinical pharmacology and therapeutics.

[25]  F. Ragab,et al.  Design, synthesis and structure-activity relationship of novel semi-synthetic flavonoids as antiproliferative agents. , 2014, European journal of medicinal chemistry.

[26]  F. Gonzalez,et al.  Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7. , 2014, Toxicology and applied pharmacology.

[27]  Jim Euchner.  Design , 2014, Catalysis from A to Z.

[28]  Jin Zhou,et al.  Potential pharmacokinetic interactions of therapeutic cytokines or cytokine modulators on small-molecule drugs: mechanistic understanding via studies using in vitro systems , 2014, Drug metabolism and drug interactions.

[29]  Wei Huang,et al.  Efficient synthesis and antiproliferative activity of novel thioether-substituted flavonoids. , 2013, European journal of medicinal chemistry.

[30]  Yan-Yan Zhang,et al.  Deglycosylation of Liquiritin Strongly Enhances its Inhibitory Potential Towards UDP‐Glucuronosyltransferase (UGT) Isoforms , 2013, Phytotherapy research : PTR.

[31]  N. Lu,et al.  Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma , 2013, Cell Death and Disease.

[32]  Guangbo Ge,et al.  The Inhibitory Effect of 20(S)‐Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7 , 2013, Phytotherapy research : PTR.

[33]  Hyung Keun Kim,et al.  Baicalin from Scutellaria baicalensis impairs Th1 polarization through inhibition of dendritic cell maturation. , 2013, Journal of pharmacological sciences.

[34]  S. Zeng,et al.  Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. , 2012, Current drug metabolism.

[35]  Xinxin Ding,et al.  Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[36]  Shuxing Zhang,et al.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1. , 2011, Molecular pharmaceutics.

[37]  J. Potter,et al.  Determinants of Aspirin Metabolism in Healthy Men and Women: Effects of Dietary Inducers of UDP-Glucuronosyltransferases , 2011, Lifestyle Genomics.

[38]  R. Frye,et al.  Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. , 2011, Planta medica.

[39]  N. Oberlies,et al.  Influence of dietary substances on intestinal drug metabolism and transport. , 2010, Current drug metabolism.

[40]  G. Desideri,et al.  Flavonoids: Antioxidants Against Atherosclerosis , 2010, Nutrients.

[41]  Andrew G Mercader,et al.  QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. , 2010, European journal of medicinal chemistry.

[42]  Wei Liu,et al.  Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes , 2010, Pharmaceutical Research.

[43]  Shuji Ohno,et al.  Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction , 2009, Drug Metabolism and Disposition.

[44]  Shixuan Zhang,et al.  Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: synthesis, SAR analysis, and biological activity. , 2008, Bioorganic & medicinal chemistry.

[45]  P. Ruzza,et al.  Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. , 2008, Biochemical pharmacology.

[46]  V. Tam,et al.  Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. , 2007, Molecular pharmaceutics.

[47]  I. Mcintosh,et al.  Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme , 2007, Drug Metabolism and Disposition.

[48]  S. Mertens-Talcott,et al.  Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. , 2007, Journal of agricultural and food chemistry.

[49]  Andrew J Lamb,et al.  Antimicrobial activity of flavonoids , 2005, International Journal of Antimicrobial Agents.

[50]  C. Guillemette,et al.  Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. , 2005, Pharmacogenetics and genomics.

[51]  J. Potter,et al.  GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES , 2005, Drug Metabolism and Disposition.

[52]  Tony K L Kiang,et al.  UDP-glucuronosyltransferases and clinical drug-drug interactions. , 2005, Pharmacology & therapeutics.

[53]  Barry C. Jones,et al.  DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.

[54]  T. Goosen,et al.  Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[55]  P. Hollman.  Absorption, Bioavailability, and Metabolism of Flavonoids , 2004 .

[56]  Chi-Tang Ho,et al.  Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[57]  R. Green,et al.  Mechanism of indinavir-induced hyperbilirubinemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Wrighton,et al.  The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*† , 2001, Drug metabolism reviews.

[59]  E. Middleton,et al.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.

[60]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[61]  H. Maeda,et al.  Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. , 1999, Journal of agricultural and food chemistry.

[62]  F. Fazio,et al.  Errors Introduced by Tissue Heterogeneity in Estimation of Local Cerebral Glucose Utilization with Current Kinetic Models of the [18F]Fluorodeoxyglucose Method , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  Alan Symmons,et al.  ABSORPTION , 1981 .

[64]  Richard Barnett.  Diabetes , 1904, The Lancet.

[65]  Aamir Ahmad,et al.  Flavonoids-induced redox cycling of copper ions leads to generation of reactive oxygen species: A potential role in cancer chemoprevention. , 2018, International journal of biological macromolecules.

[66]  Manisha J. Oza,et al.  Diabetes, diabetic complications, and flavonoids , 2016 .

[67]  J. Brockmöller,et al.  Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. , 2014, Pharmacology & therapeutics.

[68]  A. Kunze.  Prediction of human drug clearance and anticipation of clinical drug-drug interaction potential from in vitro drug transport studies , 2014 .

[69]  S. Moro,et al.  Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. , 2010, Drug metabolism and pharmacokinetics.

[70]  G. Rusak,et al.  Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. , 2010, European journal of medicinal chemistry.

[71]  E. Middleton.  Effect of plant flavonoids on immune and inflammatory cell function. , 1998, Advances in experimental medicine and biology.